Investing.com - Financial Markets Worldwide
Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

FTSE 100 set to record weekly gains on earnings, vaccine optimism

Published 05/02/2021, 09:18
Updated 05/02/2021, 09:24
© Reuters.
UK100
-
BEZG
-
FTMC
-
FTNMX301010
-
FTNMX405010
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 down 0.1%, FTSE 250 adds 0.2%

Feb 5 (Reuters) - London's FTSE 100 was set to record a
weekly gain of 1% on Friday, after falling for three consecutive
weeks, as corporate earnings improved and faster vaccine
rollouts supported optimism around a quicker pace of economic
revival.
The blue-chip FTSE 100 index .FTSE dipped 0.1% on Friday
but was on pace to gain 1.06% for the week with banks
.FTNMX8350 and travel .FTNMX5750 stocks being the top
gainers. The mid-cap index .FTMC gained rose 0.2%.
The Bank of England gave British lenders at least six
months' breathing space on Thursday before negative interest
rates are a possibility, focusing instead on the prospects of a
post-lockdown rebound. Progress in vaccine distribution and expectations of a large
stimulus by U.S. President Joe Biden's administration helped
global markets trade near their record highs. MKTS/GLOB
Insurer Beazley BEZG.L jumped 7.2% and was the top gainer
on the mid-cap index after it said it was confident of returning
to profitability in 2021.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.